Navigation Links
CapSureSP Novus

ProductsCapSureSP Novus
Company Medtronic Inc.
Item CapSureSP Novus
Features CapSureSP Novus 5594 provides the stable, low pacing thresholds and large sensing potentials.
Description CapSureSP Novus 5594 is a J-shaped, endocardial, tined pacing lead. provide the stable, low pacing thresholds and large sensing potentials already proven with CapSure SP steroid-eluting leads but within an even smaller lead body.
Info Medtronic Inc.
Customer Service: (800) 551-5544
Web site: http://www.medtronic.com/

Related medicine products :

1. Novus 2000 argon laser
2. Novus Valve Systems
3. CapSureFix Novus Lead Tip
4. CapSure SP Novus
5. CapSureZ Novus
6. CapSure Novus
7. CapSureFix Novus
8. Novus Varia
9. Novus Verdi
10. Novus Varia Three Color Photocoagulator
11. Novus Spectra Photocoagulator
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products:
(Date:12/15/2009)... 15 Reportlinker.com announces that ... available in its catalogue: ,, ... the U.S. and its International Trade ... http://www.reportlinker.com/p0167482/In-Vitro-Diagnostic-Substance-Manufacturing-Industry-in-the-US-and-its-International-Trade-[Q4-2009-Edition].html ,, The newly published ... provides the latest market research on ...
(Date:12/15/2009)... Dec. 15 Reportlinker.com announces ... is available in its catalogue: ,, ... Therapeutics - Market Forecasts to 2015, ... Analysis ,, http://www.reportlinker.com/p0168098/The-Future-of-Cardiovascular-Diseases-Therapeutics---Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html ... author has released its latest research ...
(Date:12/15/2009)... Research shows a direct correlation between ... as building a culture of health improvement can ... to a new white paper from The Vitality ... workplace represents an ideal setting for the delivery ... sustaining a corporate culture of health is a ...
(Date:12/15/2009)... cells may offer a new option to treat about ... amplified signaling of the epidermal growth factor receptor (EGFR), ... Jonsson Comprehensive Cancer Center. , Rapidly dividing cancer cells ... The fatty acids also provide an alternative energy source ... regulating cell signaling, said Dr. Paul Mischel, a professor ...
(Date:12/15/2009)... by The University of Western Ontario reveals that couples ... report higher average measures of happiness and life satisfaction ... roles, category, where each partner,s unpaid work is within ... a growing category that now represents more than 25 ... be in a shared roles model when women have ...
Breaking Medicine News(10 mins):Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 2Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 3Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 4Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 5Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 6Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 7Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 8Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 2Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 3Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 4Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 5Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 6Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 7Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 8Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 9Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 10Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 11Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 12Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 13Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 14Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 15Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 16Health News:Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 17Health News:Optimizing Corporate Culture is Critical to the Success of Wellness Programs 2Health News:Targeting brain cancer cell metabolism may provide new treatment 2Health News:Targeting brain cancer cell metabolism may provide new treatment 3
... get the blues during the course of the winter and ... far more difficult to overcome the seasonal affective disorder (SAD), ... ,Those who suffer from SAD overeat, sleep ... irritability and depression and develop an aversion to social interactions. ...
... In a study it has been revealed that in the ... number of children.// ,This is as per Statistics Canada. ... at a quick pace.,The year 2015 will have number of ... children under the age of 15. ,Also by 2031, ...
... the bacteria responsible for causing tooth decay, are able ... that is considered// vital for the survival of normal ... have revealed that the tooth decay causing bacteria can ... were met with skepticism … because the dogma was ...
... A new blood test that can detect non-small cell lung ... the University of Kentucky. The test is highly accurate// and ... identified by advanced CT scans. ,The University has ... development of a test to detect lung cancer in smokers ...
... and Technology Committee has issued a warning that if a ... a severe shortage of food. // ,The ... on an international level and has asked the Government to ... arise. As staff continue to take leave and supermarket deliveries ...
... is well known how nutritional dense milk is ... and to develop valuable new products with nutraceutical, ... been initiated in The University of Queensland's Institute ... R&D company. Microbial Screening Technologies (MST) has teamed ...
Other Medicine News:
(Date:12/15/2009)... Dec. 15 Varian Medical Systems (NYSE: ... results for first quarter of fiscal year 2010 following ... 2010. The news release will be followed by ... p.m. PT. The news release and a link ... the company website at: www.varian.com/investor . To ...
(Date:12/15/2009)... Calif., Dec. 15 Masimo (Nasdaq: ... Measure-Through Motion and Low Perfusion pulse oximetry, today ... has been awarded the 2009 Frost & Sullivan ... American Patient Monitoring market. According to Frost & ... Mr. Kiani,s "unprecedented ability in understanding customer requirements, ...
(Date:12/15/2009)... Rib-X Pharmaceuticals, Inc., a company focused ... drugs for the treatment of serious multi-drug-resistant infections ... research agreement with Massachusetts General Hospital (MGH). ... collaboration, Dr. David Hooper of MGH will evaluate ... model to determine resistance development and to validate ...
Breaking Medicine Technology:Varian Medical Systems Schedules First Quarter FY2010 News Release and Conference Call 2Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award 2Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award 3Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award 4Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award 5Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award 6Rib-X Pharmaceuticals Enters into Collaborative Agreement on Delafloxacin with Massachusetts General Hospital 2Rib-X Pharmaceuticals Enters into Collaborative Agreement on Delafloxacin with Massachusetts General Hospital 3American Community Introduces Latitude 28TM 29 Health Plan for Employer Groups in Nebraska 55321 1American Community Introduces Latitude 28TM 29 Health Plan for Employer Groups in Nebraska 55321 2NexBio 28R 29 Demonstrates DAS181 28Fludase 28R 29 29 a Broad Spectrum Drug Candidate Inhibits Influenza Viral Infection in Human Lung Tissue 13689 1NexBio 28R 29 Demonstrates DAS181 28Fludase 28R 29 29 a Broad Spectrum Drug Candidate Inhibits Influenza Viral Infection in Human Lung Tissue 13689 2NexBio 28R 29 Demonstrates DAS181 28Fludase 28R 29 29 a Broad Spectrum Drug Candidate Inhibits Influenza Viral Infection in Human Lung Tissue 13689 3NexBio 28R 29 Demonstrates DAS181 28Fludase 28R 29 29 a Broad Spectrum Drug Candidate Inhibits Influenza Viral Infection in Human Lung Tissue 13689 4SuperSonic Imagine Receives FDA Approval for Aixplorer Ultrasound System 13688 1SuperSonic Imagine Receives FDA Approval for Aixplorer Ultrasound System 13688 2SuperSonic Imagine Receives FDA Approval for Aixplorer Ultrasound System 13688 3SuperSonic Imagine Receives FDA Approval for Aixplorer Ultrasound System 13688 4